Use of Fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders

Details for Australian Patent Application No. 2004308452 (hide)

International Classifications

Event Publications

20 July 2006 PCT application entered the National Phase

PCT publication WO2005/062929 Priority application(s): WO2005/062929

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

20 November 2008 Alteration of Name

The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc. 2005 Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.